Biotech
The Digital Health Sector Financing Plummets by 48% in 2023
There are also signs to anticipate the entry into a consolidation phase of the digital health business. The merger and acquisition (M&A) of companies in this area almost doubled in the fourth quarter of 2023. The report’s authors believe that if private investment continues to decline alongside initial public offerings (IPOs), M&A will flourish as the best option for cash-strapped companies.
Investment in the digital health sector continues to fall. The fundraising in 2023 of €12.15 billion in 1,397 fundraising agreements represents a return to figures not recorded since 2016 or 2014: a setback of a decade. In this context, the United States continues to be the country that obtains the most investment in this sector, taking more than half of the agreements. This is stated in the State of Digital Health 2023 Report from the market intelligence platform CB Insights.
According to this report, mega-funding rounds in the digital health sector have almost disappeared, falling to three rounds of more than $100 million (€92 million) in the fourth quarter of last year, the lowest figure since 2016. In total, in 2023 there were 20 mega rounds, falling well below the average number of rounds of this type per quarter in 2021. But despite these unflattering figures, the average deal stood at €3.68 million, the highest since data is recorded in this area.
2023 was also the year of the collapse of the digital health unicorns, according to the CB Insights report. For the first time, the loss of companies of this size has exceeded the consolidation of this type of company , a trend that is explained by a mix between the disappearance of startups and the fall in investment.
Find out why investments in the digital health sector have fallen in 2023 and read the most important financial news of the day with our companion app Born2Invest.
The M&A dynamics of the fourth quarter of last year indicate that the digital health sector would be consolidating
There are also signs to anticipate the entry into a consolidation phase of the digital health business. The merger and acquisition (M&A) of companies in this area almost doubled in the fourth quarter of 2023. The report’s authors believe that if private investment continues to decline alongside initial public offerings (IPOs), M&A will flourish as the best option for cash-strapped companies.
The areas of care delivery and navigation technology continue to be those that attract the most investment after raising more than €770 million in the fourth quarter of last year. These areas are followed by diagnostic, imaging and monitoring technologies with €461 million.
__
(Featured image by geralt via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Crypto1 week ago
Solana Surges: Trump’s White House Win Fuels Anticipation for SOL ETFs
-
Impact Investing1 day ago
Intesa Sanpaolo Enters Radoff’s Capital
-
Crypto1 week ago
XRP Hits Annual High: ETFs on the Horizon as Ripple Stays Optimistic
-
Biotech2 weeks ago
Rovi Cuts Its Profit by 4% in the First Nine Months, to 113.5 Million